Who owns Threshold Pharmaceuticals?

Key details on Threshold Pharmaceuticals (Ticker: THLD)

Who owns Threshold Pharmaceuticals?

Is THLD a good stock to own? Find out who bought Threshold Pharmaceuticals, who sold Threshold Pharmaceuticals (THLD) stock, and who holds a large position in Threshold Pharmaceuticals.

Fund Name Number of Shares Share Valuation As Of
Federated Investors 3.93M $15.98M Sept. 30, 2015
Baker Bros. Advisors 2.93M $11.91M Sept. 30, 2015
Franklin Resources 2.76M $11.22M Sept. 30, 2015
JPMORGAN CHASE & CO 2.53M $9.14M Sept. 30, 2014
Vanguard 2.39M $1.15M Dec. 31, 2015
UBS GLOBAL ASSET MANAGEMENT AMERICAS 1.95M $7.92M Sept. 30, 2015
BlackRock Institutional Trust Company, N.A. 1.80M $864907 Dec. 31, 2015
AXA 1.77M $7.20M Sept. 30, 2015
BlackRock Fund Advisors 1.70M $816823 Dec. 31, 2015
Millennium Management 1.54M $6.28M Sept. 30, 2015
Wells Fargo & Company 1.50M $11.12M June 30, 2012
Adage Capital Partners GP 1.38M $7.28M June 30, 2013
First Eagle Investment Management 1.27M $5.13M June 30, 2015
PointState Capital 1.20M $10.56M March 31, 2012
Straus Capital Management 1.17M $7.94M June 30, 2012
Deutsche Bank Aktiengesellschaft 1.07M $4.33M June 30, 2015
FMR 1.06M $4.33M Sept. 30, 2015
T. Rowe Price Associates 1.05M $4.89M Sept. 30, 2013
Oxford Asset Management 995046 $8.76M March 31, 2012
STATE STREET CORPORATION 856291 $3.49M Sept. 30, 2015
Ayer Capital Management 792846 $3.34M Dec. 31, 2012
Charles Schwab Investment Management 779451 $3.71M March 31, 2014
Technical Financial Services 773262 $3.15M Sept. 30, 2015